Data Characteristics for This Category
Market access product data in the biopharmaceutical sector primarily originates from regulatory documents, guidelines, and approval records published by national drug regulatory agencies. Additional sources include reports from industry associations and professional consulting firms. Data update frequencies vary; regulatory documents typically have defined revision cycles or ad-hoc updates, while approval information changes in real-time with product registration progress.
The documentation is predominantly unstructured text, such as PDF-formatted laws and regulations, approval notifications, expert review opinions, and clinical trial reports. Fields and units are highly specialized, covering generic drug names, indications, registration classifications, approval numbers, marketing authorization holders, review conclusions, effective dates, validity periods, and fee standards. Some data may include dosage units (e.g., mg/kg), time units (e.g., weeks, months), and currency units (e.g., USD, EUR).
Constraints Imposed by These Characteristics on Multi-Turn Conversations and Prompts
The highly specialized and unstructured nature of market access data places specific demands on the accuracy of multi-turn conversations and prompt design. The complexity of regulatory documents means the model must process long texts, understand legal terminology, and navigate nested logic. This requires prompts to guide the model toward deep semantic understanding.
The timeliness of approval information requires the knowledge base to update quickly and cite the latest data in multi-turn conversations. Multiple document formats increase the difficulty of information extraction; prompts must guide the model to unify information from different data structures. The strictness of fields and units means the model must precisely cite or convert them in responses. Prompts should emphasize output accuracy and standardization, avoiding vague statements or unit errors. For example, if a user queries the approval status of a specific drug, the model must recall relevant approval numbers and dates and explain their legal significance in a particular country or region.
Configuration Settings
| Configuration Item | Recommended Value | Rationale for Recommendation |
|---|---|---|
maxContext | 8 | Ensures the model can review enough historical conversation turns to understand regulatory details and approval processes within the context. |
Chunk size (Segment Length) | 800–1200 characters (characters) | Accommodates the common long sentences and complex paragraphs found in regulatory documents and approval reports, ensuring semantic integrity. |
Recall count (Recall Count) | Top 5 entries (Top 5) | Balances recall breadth with model processing load, ensuring retrieval of the most relevant regulatory or approval information snippets. |
Similarity threshold (Similarity Threshold) | 0.75–0.85 | Accurately matches user queries with highly specialized market access terminology, reducing irrelevant results. |
Rerank result count (Reranked Return Count) | Top 3 entries (Top 3) | Further optimizes ranking based on recall, prioritizing the most relevant clauses or cases for the current conversation. |
prompt | Calibrate by actual measurement | Must include clear instructions that guide the model to focus on key information like regulatory provisions, approval status, and fee standards, and require citation of original text. |
Three Common Mistakes
- Model responses contain outdated or inaccurate regulatory provisions. This occurs because the knowledge base update mechanism is inadequate, failing to synchronize with the latest regulatory policy changes in time.
- After a user query, the model cannot provide specific approval numbers or effective dates, offering only general regulatory explanations. This happens because prompts fail to explicitly require the model to extract and cite factual data, or relevant fields in the vector store are not effectively indexed.
- During the conversation, the model repeatedly asks for already provided information or gives contradictory answers. This is due to
maxContextbeing set too low, preventing the model from effectively maintaining multi-turn conversational coherence.
How to Confirm Proper Configuration
- Construct test cases that include both old and new regulations, as well as the latest approval statuses, to verify if the model can cite the most current information.
- Engage in multi-turn conversations about complex issues such as specific drug market access pathways and fee standards. Evaluate whether the model can accurately extract and integrate key field information.
- Check if the model's responses clearly cite sources (e.g., regulation names, clause numbers, approval numbers) and verify the accuracy of these citations.
- Assess whether the model maintains contextual consistency in long conversations, avoiding repetitive questions or information omissions. This can be determined by tracking the transfer of key information within the conversation history.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.